These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ceftazidime: summary of the first international symposium. Young LS J Antimicrob Chemother; 1981 Sep; 8 Suppl B():349-52. PubMed ID: 19803013 [No Abstract] [Full Text] [Related]
3. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients. Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802 [No Abstract] [Full Text] [Related]
4. The microbiological assay of ceftazidime. Thornton JE J Antimicrob Chemother; 1981 Sep; 8 Suppl B():225-6. PubMed ID: 19802989 [No Abstract] [Full Text] [Related]
5. Bacteriological investigations with ceftazidime in vitro. Grimm H J Antimicrob Chemother; 1981 Sep; 8 Suppl B():213-6. PubMed ID: 19802986 [No Abstract] [Full Text] [Related]
7. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics. Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin. Harris AM; Plested SJ; Harper PB J Antimicrob Chemother; 1981 Sep; 8 Suppl B():43-5. PubMed ID: 19810168 [No Abstract] [Full Text] [Related]
9. Behaviour of ceftazidime towards beta-lactamases. Labia R; Beguin-Billecoq R; Guionie M J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176 [TBL] [Abstract][Full Text] [Related]
10. Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes. Armstrong BK; Mehta S; Kim SJ Retina; 2011 Nov; 31(10):2134-6. PubMed ID: 22027802 [No Abstract] [Full Text] [Related]
16. The in-vitro activity of ceftazidime against clinically important pathogens. Knothe H; Dette GA J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167 [TBL] [Abstract][Full Text] [Related]
17. Ceftazidime (Fortaz). Med Lett Drugs Ther; 1985 Oct; 27(698):85-7. PubMed ID: 3900663 [No Abstract] [Full Text] [Related]
18. Use of ceftazidime in severe Gram-negative infections--a preliminary study. Clumeck N; Vanlaethem Y; Gordts B; Jaspar N; Butzler JP J Antimicrob Chemother; 1981 Sep; 8 Suppl B():317-21. PubMed ID: 19803007 [TBL] [Abstract][Full Text] [Related]
19. The susceptibility of nosocomial pathogens to ceftazidime. Brumfitt W; Hamilton-Miller JM J Antimicrob Chemother; 1981 Sep; 8 Suppl B():15-21. PubMed ID: 19802966 [TBL] [Abstract][Full Text] [Related]